Allen J. Naftilan

3.4k total citations · 1 hit paper
47 papers, 2.7k citations indexed

About

Allen J. Naftilan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Allen J. Naftilan has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Molecular Biology. Recurrent topics in Allen J. Naftilan's work include Hormonal Regulation and Hypertension (13 papers), Heart Failure Treatment and Management (11 papers) and Renin-Angiotensin System Studies (11 papers). Allen J. Naftilan is often cited by papers focused on Hormonal Regulation and Hypertension (13 papers), Heart Failure Treatment and Management (11 papers) and Renin-Angiotensin System Studies (11 papers). Allen J. Naftilan collaborates with scholars based in United States, India and Greece. Allen J. Naftilan's co-authors include Richard E. Pratt, Victor J. Dzau, Suzanne Oparil, Ya‐Fang Chen, Richard E. Katholi, V J Dzau, Steven K. Hanks, Thomas R. Polte, Andrew S. Kraft and Hui-Feng Lin and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Allen J. Naftilan

47 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

1989 543 citations Allen J. Naftilan, Richard E. Pratt et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allen J. Naftilan United States	24	1.5k	975	850	342	270	47	2.7k
Naro Ohashi Japan	34	1.4k 0.9×	870 0.9×	1.0k 1.2×	269 0.8×	230 0.9×	119	3.3k
Jasmina Varagić United States	35	1.7k 1.1×	622 0.6×	821 1.0×	276 0.8×	265 1.0×	97	2.7k
Hendrik Buikema Netherlands	30	1.3k 0.9×	583 0.6×	743 0.9×	418 1.2×	497 1.8×	111	2.5k
Christos Tikellis Australia	25	1.3k 0.9×	1.1k 1.1×	1.2k 1.4×	531 1.6×	339 1.3×	30	3.7k
Dingliang Zhu China	33	1.3k 0.8×	715 0.7×	451 0.5×	406 1.2×	269 1.0×	119	2.7k
Stephan Holmer Germany	29	2.1k 1.4×	711 0.7×	952 1.1×	452 1.3×	278 1.0×	80	3.2k
Nobuyuki Ura Japan	27	1.3k 0.9×	551 0.6×	754 0.9×	329 1.0×	582 2.2×	98	3.2k
Günter Wolf Germany	34	1.1k 0.7×	1.6k 1.6×	722 0.8×	448 1.3×	352 1.3×	70	4.5k
Hans Herlitz Sweden	30	1.1k 0.7×	428 0.4×	745 0.9×	495 1.4×	352 1.3×	155	2.9k
William P. Dole United States	34	1.9k 1.2×	660 0.7×	1.0k 1.2×	635 1.9×	397 1.5×	84	3.7k

Countries citing papers authored by Allen J. Naftilan

Since Specialization

Citations

This map shows the geographic impact of Allen J. Naftilan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen J. Naftilan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen J. Naftilan more than expected).

Fields of papers citing papers by Allen J. Naftilan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen J. Naftilan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen J. Naftilan. The network helps show where Allen J. Naftilan may publish in the future.

Co-authorship network of co-authors of Allen J. Naftilan

This figure shows the co-authorship network connecting the top 25 collaborators of Allen J. Naftilan. A scholar is included among the top collaborators of Allen J. Naftilan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen J. Naftilan. Allen J. Naftilan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Shouzuo, Deepak K. Gupta, Hui Nian, et al.. (2021). Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan. Journal of Cardiac Failure. 27(11). 1231–1239. 9 indexed citations

Maltais, Simon, Antonis K. Hatzopoulos, Thomas G. DiSalvo, et al.. (2013). Stem cell therapy for chronic heart failure: an updated appraisal. Expert Opinion on Biological Therapy. 13(4). 503–516. 9 indexed citations

Storrow, Alan B., Christopher J. Lindsell, Sean P. Collins, et al.. (2012). Standardized Reporting Criteria for Studies Evaluating Suspected Acute Heart Failure Syndromes in the Emergency Department. Journal of the American College of Cardiology. 60(9). 822–832. 5 indexed citations

Collins, Sean P., Cathy A. Jenkins, Karen F. Miller, et al.. (2012). Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure. PubMed. 5(1). 9–15. 8 indexed citations

Collins, Sean P., Cathy A. Jenkins, Karen F. Miller, et al.. (2012). Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes. PubMed. 5(1). 1–8. 21 indexed citations

Fermann, Gregory J., Christopher J. Lindsell, Alan B. Storrow, et al.. (2012). Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers. 17(8). 706–713. 47 indexed citations

Collins, Sean P., Matthew Sperling, Alan B. Storrow, et al.. (2010). Urinary NGAL Levels Predict Acute Kidney Injury in Emergency Department Patients with Acute Heart Failure. Journal of Cardiac Failure. 16(8). S29–S30. 3 indexed citations

Naftilan, Allen J., et al.. (2009). 273: The Panel-Reactive Antibody Paradox: PRA Class II Predicts Rejection within 1 Year but PRA Class I Predicts Graft Survival. The Journal of Heart and Lung Transplantation. 28(2). S161–S161. 1 indexed citations

Germany, Robin, et al.. (2009). Integrating Device Diagnostic Data into a Disease Management Care Model. Heart & Lung. 38(3). 270–270. 1 indexed citations

10.

Naftilan, Allen J., et al.. (2000). Vasopeptidase inhibition: A new direction in cardiovascular treatment. Current Hypertension Reports. 2(4). 384–391. 7 indexed citations

11.

Wyatt, Todd A., Allen J. Naftilan, Sharron H. Francis, & Jackie D. Corbin. (1998). ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 274(2). H448–H455. 79 indexed citations

12.

Chen, Yan, et al.. (1996). Multiple Enhancer Elements Mediate Induction of c- fos in Vascular Smooth Muscle Cells. Hypertension. 27(6). 1224–1233. 7 indexed citations

13.

Niimura, Fumio, Patricia A. Labosky, Junji Kakuchi, et al.. (1995). Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.. Journal of Clinical Investigation. 96(6). 2947–2954. 275 indexed citations

14.

Polte, Thomas R., Steven K. Hanks, & Allen J. Naftilan. (1994). Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II. Journal of Cellular Biochemistry. 55(1). 106–119. 112 indexed citations

15.

Naftilan, Allen J.. (1994). Role of the tissue renin-angiotensin system in vascular remodeling and smooth muscle cell growth. Current Opinion in Nephrology & Hypertension. 3(2). 218–227. 26 indexed citations

16.

Naftilan, Allen J., et al.. (1991). Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall.. Journal of Clinical Investigation. 87(4). 1300–1311. 108 indexed citations

17.

Pratt, Richard E., Wenbo Zou, Allen J. Naftilan, Julie R. Ingelfinger, & Victor J. Dzau. (1989). Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat. American Journal of Physiology-Renal Physiology. 256(3). F469–F474. 41 indexed citations

18.

Naftilan, Allen J. & Suzanne Oparil. (1982). The role of calcium in the control of renin release.. Hypertension. 4(5). 670–675. 42 indexed citations

19.

Naftilan, Allen J. & Suzanne Oparil. (1981). Effects of sodium intake and Goldblatt hypertension on renin release in rat kidney slices. American Journal of Physiology-Renal Physiology. 240(6). F501–F507. 9 indexed citations

20.

Naftilan, Allen J. & Suzanne Oparil. (1978). Inhibition of renin release from rat kidney slices by the angiotensins. American Journal of Physiology-Renal Physiology. 235(1). F62–F68. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact